Literature DB >> 3705464

Fate of influenza A virion proteins after entry into subcellular fractions of LLC cells and the effect of amantadine.

D D Richman, K Y Hostetler, P J Yazaki, S Clark.   

Abstract

Influenza A virus entry into the host cell was studied by monitoring the fate of virion proteins in subcellular fractions of LLC-RMK2 cells under conditions of low multiplicity of infection in the absence of drugs. Adsorption but not entry could be demonstrated at 4 degrees. Restricted entry into a prelysosomal pool could be demonstrated at 20 degrees. At 37 degrees proteins entered the cell in the same relative distribution as present in virions arguing against the fusion hypothesis and for the endocytosis hypothesis. The hemagglutinin and matrix proteins were readily degraded intracellularly at 37 degrees, but the nucleoprotein was relatively resistant to degradation, also consistent with the latter hypothesis. Amantadine blocked neither entry into the host cell nor transfer between the prelysosomal and lysosomal compartments; however, it appeared to block exit from the prelysosomal and lysosomal pools. The addition of the drug reduced degradation of the matrix protein in these pools but not of the hemagglutinin, consistent with inhibition by amantadine of fusion of virion envelope and vesicle membrane.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3705464     DOI: 10.1016/0042-6822(86)90042-5

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  7 in total

1.  Hemagglutinin 1-specific immunoglobulin G and Fab molecules mediate postattachment neutralization of influenza A virus by inhibition of an early fusion event.

Authors:  M J Edwards; N J Dimmock
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

Review 2.  Antiviral therapy: current concepts and practices.

Authors:  B Bean
Journal:  Clin Microbiol Rev       Date:  1992-04       Impact factor: 26.132

3.  Mass action kinetics of virus-cell aggregation and fusion.

Authors:  J Bentz; S Nir; D G Covell
Journal:  Biophys J       Date:  1988-09       Impact factor: 4.033

4.  Use of FITC-labeled influenza virus and flow cytometry to assess binding and internalization of virus by monocytes-macrophages and lymphocytes.

Authors:  J E Nichols; D J Mock; N J Roberts
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

Review 5.  Virus entry into animal cells.

Authors:  M Marsh; A Helenius
Journal:  Adv Virus Res       Date:  1989       Impact factor: 9.937

Review 6.  Antiviral chemotherapy and prophylaxis of viral respiratory disease.

Authors:  S J Sperber; F G Hayden
Journal:  Clin Lab Med       Date:  1987-12       Impact factor: 1.935

7.  Antiviral activity of an aqueous extract derived from Aloe arborescens Mill. against a broad panel of viruses causing infections of the upper respiratory tract.

Authors:  B Glatthaar-Saalmüller; A M Fal; K Schönknecht; F Conrad; H Sievers; A Saalmüller
Journal:  Phytomedicine       Date:  2015-07-02       Impact factor: 5.340

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.